SkyX Group

SkyX Group is a biotechnology and medical device company based in New York City, aiming to revolutionize the future with its slogan "Building an inhalable future". Established in 2020, the company specializes in developing cutting-edge aerosol delivery devices for both consumer and medical usage. With a robust R&D portfolio, SkyX caters to the pharmaceutical and biotech sectors for the inhalation of diverse active ingredients. The company boasts a formidable intellectual property arsenal, encompassing patents not only on hardware and chemical formulations but also on age/user-verification, IoT enabled devices, sustainability solutions, and supply chain optimization. Given its expertise in Biotechnology, Hardware, Health Care, Information Technology, and Manufacturing, SkyX positions itself at the forefront of innovation in multiple industries. While the specifics of the latest investment and its investors remain undisclosed, SkyX represents an intriguing prospect in the burgeoning biotech and medical device landscape. Its commitment to pioneering aerosol delivery technology makes it a noteworthy player in the healthcare and consumer product markets. For further insights, interested parties can visit their website at www.skyxgroup.com.